CVE-2023-32662

Improper authorization in some Intel Battery Life Diagnostic Tool installation software before...

6.7 Medium

Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.

Attack profile

How easy it is to exploit

Attack vector: Local
Complexity: Low
Privileges needed: High
User interaction: None

What an attacker can affect

Confidentiality: High
Integrity: High
Availability: High

Exploit likelihood

0.23%Up 0.2 points since Nov 15, 2023

What each source reports

CVE List Score used 6.7

Record: CVE-2023-32662
CVSS 3.1: 6.7 MediumCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness: CWE-285, CWE-285
Updated: 2026-11-02

EUVDEUVD-2023-36905 6.7

Record: EUVD-2023-36905
CVSS 3.1: 6.7 MediumCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Updated: 2026-11-03

GitHub AdvisoriesGHSA-qpw8-mj26-5rc9 6.7

Improper authorization in some Intel Battery Life Diagnostic Tool installation software before...

Record: GHSA-qpw8-mj26-5rc9
CVSS 3.1: 6.7 MediumCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness: CWE-285
Updated: 2026-11-02

NVD 6.7

Record: CVE-2023-32662
CVSS 3.1: 6.7 MediumCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness: CWE-285
Updated: 2026-11-02

Affected products

intel battery life diagnostic tool

History

History
Recorded	Changed	Sources
Nov 3, 2026	aliases, published	EUVD
Nov 2, 2026	first indexed	CVE List, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2023-32662 is a medium vulnerability (CVSS 6.7) in Intel Battery Life Diagnostic Tool, published November 14, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.23%, the 13th percentile. No source names a fixed version.